NCI award (non-dilutive grant) further validates novel personalized off-the-shelf immunotherapy approach; and may facilitate future non-dilutive funding opportunitiesPHILADELPHIA and VANCOUVER,…
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the…
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response in follicular lymphoma patient previously…
NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer…
Dr. Davarpanah will lead Cidara’s oncology efforts, focusing on strategy to advance development candidates Previously served as Clinical and Translational…
Study evaluates the effect of combining PDS0101 with standard of care on levels of circulating HPV viral DNA in cervical…
Day One receives an exclusive license to develop and commercialize small molecule drug candidates for pediatric and adult cancers with…
Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 Study Designed to Support Planned…
STOCKHOLM, SWEDEN / ACCESSWIRE / August 16, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB (publ) today announced that the…
Pivotal Milestone Accelerates Pathway to Specific IndicationLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused…